查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489258

全球心血管数位健康市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Digital Health For Cardiovascular Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 131 Pages | 商品交期: 最快1-2个工作天内

价格

全球心血管数位健康市场需求预计将从 2023 年的 410.7 亿美元达到近 2,591 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 22.71%。

心血管护理的数位健康包括使用数位技术来监测、诊断和管理心臟相关疾病。这包括穿戴式装置、行动健康应用程式、远距医疗和电子健康记录，它们提供心率、血压和其他生命体征的持续监测和即时资料。这些技术能够及早发现心血管问题，制定个人化治疗计划，并提高患者对药物和生活方式改变的依从性。数位健康工具增强患者参与度，促进远距咨询，并允许及时干预，最终旨在改善心血管结果并减轻医疗系统的心臟病负担。

市场动态

心血管市场的数位健康是由全球心血管疾病盛行率不断扩大推动的，因此需要更好的管理和监测解决方案。穿戴式装置和远端监测系统等数位健康技术的进步透过提供即时资料和改善患者治疗结果彻底改变了心血管护理。远距医疗的日益普及，尤其是在 COVID-19 大流行期间，极大地提振了市场。此外，人工智慧和机器学习在数位健康工具中的集成，用于预测分析和个人化治疗计划，进一步推动了市场的发展。政府对数位健康创新的倡议和资助以及人们对预防性医疗保健意识的不断提高也是推动心血管市场数位健康的关键因素。然而，资料隐私问题和互通性挑战可能会在未来几年挑战心血管市场数位健康的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心血管数位健康市场的各个细分市场进行了包容性评估。心血管行业数位健康的成长和趋势为本研究提供了整体方法。

市场区隔

心血管数位健康市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按组件

  • 软体
  • 硬体
  • 服务

按最终用途

  • 患者
  • 供应商
  • 付款人
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心血管数位健康市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心血管数位健康市场的主要参与者包括 Orange Business、GE Healthcare、健康资讯管理系统 (HIMS)、苹果、西门子 Healthineers AG、甲骨文 (Cerner Corporation)、NXGN Management LLC、三星、Doven、CardiAI、AliveCor Inc. 、Verily Life Sciences LLC、HeartFlow Inc.、Bardy Diagnostics Inc.、Vista AI、Viz Ai、RSIP Vision、Cleerly Inc.。未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：心血管数位健康 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按组件分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球心血管数位健康市场分析：按组成部分

  • 按组件概述
  • 按组成部分的历史和预测资料分析
  • 软体
  • 硬体
  • 服务

第 6 章：全球心血管数位健康市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 患者
  • 供应商
  • 付款人
  • 其他的

第 7 章：全球心血管数位健康市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：心血管公司数位健康的竞争格局

  • 心血管市场竞争的数位健康
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Orange Business
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE Healthcare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Health Information Management Systems (HIMS)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Apple Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthineers AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Oracle (Cerner Corporation)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • NXGN Management LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Samsung
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Doven
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CardiAI
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AliveCor Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Verily Life Sciences LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • HeartFlow Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bardy Diagnostics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Vista AI
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Viz Ai
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • RSIP Vision
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cleerly Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114727

The global demand for Digital Health For Cardiovascular Market is presumed to reach the market size of nearly USD 259.1 Billion by 2032 from USD 41.07 Billion in 2023 with a CAGR of 22.71% under the study period 2024-2032.

Digital health for cardiovascular care encompasses using digital technologies to monitor, diagnose, and manage heart-related conditions. This includes wearable devices, mobile health apps, telemedicine, and electronic health records, which provide continuous monitoring and real-time data on heart rate, blood pressure, and other vital signs. These technologies enable early detection of cardiovascular issues, personalized treatment plans, and improved patient adherence to medication and lifestyle changes. Digital health tools enhance patient engagement, facilitate remote consultations, and allow for timely interventions, ultimately aiming to enhance cardiovascular outcomes and lower the burden of heart disease on healthcare systems.

MARKET DYNAMICS

The digital health for the cardiovascular market is driven by the expanding prevalence of cardiovascular diseases worldwide, necessitating better management and monitoring solutions. Advances in digital health technologies, such as wearable devices and remote monitoring systems, have revolutionized cardiovascular care by providing real-time data and enhancing patient outcomes. The increasing adoption of telemedicine, especially during the COVID-19 pandemic, has significantly boosted the market. Additionally, the integration of artificial intelligence & machine learning in digital health tools for predictive analytics and personalized treatment plans has further propelled the market. Government initiatives and funding for digital health innovations and the rising awareness about preventive healthcare are also key factors driving digital health for the cardiovascular market. However, data privacy concerns and interoperability challenges may challenge the growth of digital health for the cardiovascular market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Digital Health For Cardiovascular. The growth and trends of Digital Health For Cardiovascular industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Digital Health For Cardiovascular market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

  • Software
  • Hardware
  • Services

By End-use

  • Patients
  • Providers
  • Payers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Digital Health For Cardiovascular market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Health For Cardiovascular market include Orange Business, GE Healthcare, Health Information Management Systems (HIMS), Apple Inc., Siemens Healthineers AG, Oracle (Cerner Corporation), NXGN Management LLC, Samsung, Doven, CardiAI, AliveCor Inc., Verily Life Sciences LLC, HeartFlow Inc., Bardy Diagnostics Inc., Vista AI, Viz Ai, RSIP Vision, Cleerly Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DIGITAL HEALTH FOR CARDIOVASCULAR - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Component
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY COMPONENT

  • 5.1. Overview By Component
  • 5.2. Historical and Forecast Data Analysis By Component
  • 5.3. Software Historic and Forecast Sales By Regions
  • 5.4. Hardware Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data Analysis By End-use
  • 6.3. Patients Historic and Forecast Sales By Regions
  • 6.4. Providers Historic and Forecast Sales By Regions
  • 6.5. Payers Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE DIGITAL HEALTH FOR CARDIOVASCULAR COMPANIES

  • 8.1. Digital Health For Cardiovascular Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF DIGITAL HEALTH FOR CARDIOVASCULAR INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Orange Business
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. GE Healthcare
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Health Information Management Systems (HIMS)
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Apple Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Siemens Healthineers AG
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Oracle (Cerner Corporation)
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. NXGN Management LLC
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Samsung
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Doven
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. CardiAI
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. AliveCor Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Verily Life Sciences LLC
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. HeartFlow Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Bardy Diagnostics Inc.
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Vista AI
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Viz Ai
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments
  • 9.19. RSIP Vision
    • 9.19.1 Company Overview
    • 9.19.2 Company Revenue
    • 9.19.3 Products
    • 9.19.4 Recent Developments
  • 9.20. Cleerly Inc
    • 9.20.1 Company Overview
    • 9.20.2 Company Revenue
    • 9.20.3 Products
    • 9.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Component (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Hardware Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Patients Market Sales By Geography (USD MN)
  • Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Digital Health For Cardiovascular Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Health For Cardiovascular Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Health For Cardiovascular Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Component
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Component (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Hardware Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Patients Market Sales By Geography (USD MN)
  • Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.